MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5

Cancer Letters

Volumn 356, Issue 2, 2015, Pages 568-578

  Renjie, Wang ^a   Haiqian, Liang ^a  

^a Department of Clinical Laboratory Pingjing Hosipital Logistics College of Armed Police Forces   (China)

Author keywords

Migration and invasion; MiRNA; Pituitary tumor; Proliferation; Sox5

Indexed keywords

MICRORNA 132; MICRORNA 15A; MICRORNA 16; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR TWIST; VIMENTIN; LUCIFERASE; MESSENGER RNA; MICRORNA; MIRN132 MICRORNA, HUMAN; MIRN15 MICRORNA, HUMAN; MIRN16 MICRORNA, HUMAN; SOX5 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; MALE; PITUITARY TUMOR CELL LINE; PROTEIN RNA BINDING; RNA ANALYSIS; SOX5 GENE; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; UPREGULATION; APOPTOSIS; CANCER STAGING; CELL MOTION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR INVASION; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PITUITARY NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOXD TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84919444358     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.10.003     Document Type: Article

References (25)

1. Ezzat S., Asa S.L. Mechanisms of disease: the pathogenesis of pituitary tumors. Nat. Clin. Pract. Endocrinol. Metab 2006, 2:220-230.
2. Jiang X., Zhang X. The molecular pathogenesis of pituitary adenomas: an update. Endocrinol. Metab. (Seoul) 2013, 28:245-254.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Calin G.A., Sevignani C., Dan Dumitru C., Hyslop T., Noch E., Yendamuri S., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2999-3004.
5. Mao Z.G., He D.S., Zhou J., Yao B., Xiao W.W., Chen C.H., et al. Differential expression of microRNAs in GH-secreting pituitary adenomas. Diagn. Pathol 2010, 5:79.
6. Bottoni A., Zatelli M.C., Ferracin M., Tagliati F., Piccin D., Vignali C., et al. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J. Cell. Physiol 2007, 210:370-377.
7. Bottoni A., Piccin D., Tagliati F., Luchin A., Zatelli M.C., Degli Uberti E.C. miR-15a and miR-16-1 down-regulation in pituitary adenomas. J. Cell. Physiol 2005, 204:280-285.
8. Godoy J., Nishimura M., Webster N.J. Gonadotropin-releasing hormone induces miR-132 and miR-212 to regulate cellular morphology and migration in immortalized LbetaT2 pituitary gonadotrope cells. Mol. Endocrinol 2011, 25:810-820.
9. Zhang B.H., Pan X.P., Cobb G.P., Anderson T.A. microRNAs as oncogenes and tumor suppressors. Dev. Biol 2007, 302:1-12.
10. Bandi N., Vassella E. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol. Cancer 2011, 10:55.
11. Guo S., Xu X., Tang Y., Zhang C., Li J., Ouyang Y., et al. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. Cancer Lett 2014, 344:40-46.
12. Palmieri D., D'Angelo D., Valentino T., De Martino I., Ferraro A., Wierinckx A., et al. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis. Oncogene 2012, 31:3857-3865.
13. You J., Li Y., Fang N., Liu B., Zu L., Chang R., et al. MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2. PLoS ONE 2014, 9:e91827.
14. Li S., Meng H.M., Zhou F., Zhai L.L., Zhang L.N., Gu F., et al. MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol. Res. Pract 2013, 209:179-183.
15. Formosa A., Lena A.M., Markert E.K., Cortelli S., Miano R., Mauriello A., et al. DNA methylation silences miR-132 in prostate cancer. Oncogene 2013, 32:127-134.
16. Wei X., Tan C., Tang C., Ren G., Xiang T., Qiu Z., et al. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell. Signal 2013, 25:1037-1043.
17. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435:839-843.
18. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
19. Shi L., Jackstadt R., Siemens H., Li H., Kirchner T., Hermeking H. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer. Cancer Res 2014, 74:532-542.
20. Veronese A., Pepe F., Chiacchia J., Pagotto S., Lanuti P., Veschi S., et al. Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia. Leukemia 2014, 139:1-10.
21. Hersh C.P., Silverman E.K., Gascon J., Bhattacharya S., Klanderman B.J., Litonjua A.A., et al. SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development. Am. J. Respir. Crit. Care Med 2011, 183:1482-1489.
22. Ma S., Chan Y.P., Woolcock B., Hu L., Wong K.Y., Ling M.T., et al. DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer. Int. J. Cancer 2009, 124:2323-2332.
23. Pei X.H., Lv X.Q., Li H.X. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1. Biochem. Biophys. Res. Commun 2014, 446:322-327.
24. Ueda R., Yoshida K., Kawase T., Kawakami Y., Toda M. Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients. Int. J. Cancer 2007, 120:1704-1711.
25. Kwan K.Y., Lam M.M., Krsnik Z., Kawasawa Y.I., Lefebvre V., Sestan N. SOX5 postmitotically regulates migration, postmigratory differentiation, and projections of subplate and deep-layer neocortical neurons. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16021-16026.